These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3119777)

  • 1. Serum and CSF humoral immunity in Guillain-Barré syndrome: clinical correlations.
    Amarenco P; Sauron B; Schuller E; Chain F; Castaigne P
    J Neurol Sci; 1987 Sep; 80(2-3):129-42. PubMed ID: 3119777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy.
    Vedeler CA; Matre R; Nyland H
    Acta Neurol Scand; 1988 Nov; 78(5):401-7. PubMed ID: 2464267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra- and intrathecal production of antinerve and antibrain antibodies in Guillain-Barré syndrome: evaluation by an antibody index.
    Ryberg B
    Neurology; 1984 Oct; 34(10):1378-81. PubMed ID: 6541314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antibodies to gangliosides in Guillain-Barré syndrome.
    Ilyas AA; Willison HJ; Quarles RH; Jungalwala FB; Cornblath DR; Trapp BD; Griffin DE; Griffin JW; McKhann GM
    Ann Neurol; 1988 May; 23(5):440-7. PubMed ID: 3133978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain-barrier and intrathecal immunoglobulin changes in tuberculous meningitis and demyelinating disorders: a preliminary report from a south Indian hospital.
    Prabhakar S; Basha A; Bhagyalakshmi G; Oommen A
    Acta Neurol Scand; 1990 May; 81(5):448-51. PubMed ID: 2115723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulins in serum and cerebrospinal fluid from patients with acute Guillain-Barré syndrome.
    Vedeler CA; Matre R; Nyland H
    Acta Neurol Scand; 1986 Apr; 73(4):388-93. PubMed ID: 3727914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebrospinal fluid parameters in Guillain-Barré polyradiculitis. Importance of barrier disorder and intrathecal immunoglobulin synthesis].
    Papen R; Warecka K
    Psychiatr Neurol Med Psychol (Leipz); 1989 Jun; 41(6):334-43. PubMed ID: 2772069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleocytosis and immunoglobulin changes in cerebrospinal fluid and herpesvirus serology in patients with Guillain-Barré syndrome.
    Link H; Wahren B; Norrby E
    J Clin Microbiol; 1979 Mar; 9(3):305-16. PubMed ID: 222797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.
    Segurado OG; Krüger H; Mertens HG
    J Neurol; 1986 Aug; 233(4):202-8. PubMed ID: 3746360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
    Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
    J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
    Vedeler CA; Matre R; Sadallah S; Schifferli J
    J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
    J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological observations in Guillain-Barré syndrome.
    Sepcić J; Morović M; Rukavina D; Sepić-Grahovac D
    Acta Med Iugosl; 1990; 44(4):265-74. PubMed ID: 2091432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies.
    Dorta-Contreras A; Silva-Somoza R
    Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome: activated complement components C3a and C5a in CSF.
    Hartung HP; Schwenke C; Bitter-Suermann D; Toyka KV
    Neurology; 1987 Jun; 37(6):1006-9. PubMed ID: 3495747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG paraproteinemias: a comparative CSF and serum study.
    Arata L; Farinelli M; Panarese C; Leonardi A
    Eur Neurol; 1989; 29(1):53-5. PubMed ID: 2495967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligoclonal IgG bands in cerebrospinal fluid and serum during asymptomatic human immunodeficiency virus infection.
    Grimaldi LM; Castagna A; Lazzarin A; Pristerá R; Bianchi G; Moroni M; Roos RP
    Ann Neurol; 1988 Aug; 24(2):277-9. PubMed ID: 3140714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gm haplotypes in inflammatory demyelinating polyneuropathies.
    Feeney DJ; Pollard JD; McLeod JG; Stewart GJ; De Lange GG
    Ann Neurol; 1989 Dec; 26(6):790-2. PubMed ID: 2557797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative determination of 7 proteins in csf of patients with Guillain Barre syndrome].
    Li YT
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):289-92, 319-20. PubMed ID: 1704305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyto-dynamic observations on T lymphocytes and the CSF in Guillain-Barre syndrome].
    Diao KP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):26-8, 62. PubMed ID: 2805974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.